Market Overview

UPDATE: Morgan Stanley Initiates Quintiles Transnational at Overweight on CRO Market Leader Position

The Top 20 Wall Street Analysts Of 2015
Stocks Hitting 52-Week Highs
Quintiles Transnational Holding's (Q) CEO Thomas Pike on Q4 2015 Results - Earnings Call Transcript (Seeking Alpha)

In a report published Tuesday, Morgan Stanley analyst Ricky R. Goldwasser initiated coverage on Quintiles Transnational (NYSE: Q) with an Overweight rating and $51.00 price target.

In the report, Morgan Stanley noted, “As the contract research organization (CRO) market leader with 11% share of clinical outsourcing, a diversified customer base and backlog visibility, we believe Quintiles is best positioned to benefit from the growth in biopharmaceutical R&D outsourcing.”

Quintiles Transnational closed on Monday at $43.53.

Latest Ratings for Q

Dec 2015Goldman SachsUpgradesBuyConviction Buy
Oct 2015Avondale PartnersInitiates Coverage onSector Weight
Aug 2015Credit SuisseAssumesOutperform

View More Analyst Ratings for Q
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Initiation Analyst Ratings


Related Articles (Q)

View Comments and Join the Discussion!

Get Benzinga's Newsletters